Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure
- 29 July 2003
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 308 (3), 480-485
- https://doi.org/10.1016/s0006-291x(03)01424-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- Endothelin System: The Double-Edged Sword in Health and DiseaseAnnual Review of Pharmacology and Toxicology, 2001
- [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in manBritish Journal of Pharmacology, 2001
- Molecular and Functional Characteristics of APJJournal of Biological Chemistry, 2000
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998
- Mechanical and neuroendocrine regulation of the endocrine heartCardiovascular Research, 1996
- A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11Gene, 1993
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failureJournal of the American College of Cardiology, 1992
- Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart.JCI Insight, 1989
- Ventricular Activation of the Atrial Natriuretic Factor Gene in Acute Myocardial InfarctionNew England Journal of Medicine, 1988